Trailing-twelve-month (TTM) revenue is $2.36 Billion with a year-over-year growth of +24.10%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $580,419,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $541,173,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $603,847,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $632,630,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $2,358,069,000 |
Current P/S: $2,566,783,850 market capitalization ÷ $2,358,069,000 TTM revenue = 1.09x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:50:42.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $632.63M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:53:37.276Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|
| Capitated Revenue | N/A | $218M | $339M | $213M | $308M |
| Care Management Fee (PMPM) | $37M | $36M | $51M | $64M | $73M |
| FFS-Administrative Services |
$2.36B
$2.36 Billion
+24.10%
vs. $1.90B a year ago (TTM)
+22.35%
5 Year compound annual growth rate
1 Year
+24.10%
3 Year
+16.09%
5 Year
+22.35%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.12B | +$386.45M | +22.26% |
| 2024 | $1.74B | +$78.65M | +4.74% |
| 2023 | $1.66B | +$301.08M | +22.19% |
| 2022 | $1.36B | +$390.44M | +40.41% |
| 2021 | $966.22M | +$149.15M | +18.25% |
| 2020 |
TTM Growth
+24.10%
3-Year CAGR
+16.09%
5-Year CAGR
+22.35%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:53:37.276Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-06.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $69M |
| $95M |
| $113M |
| $125M |
| $137M |
| FFS-Patient Care | $772M | $869M | $977M | $1.1B | $1.4B |
|---|
| Other Revenue | $5M | $6M | $9M | $9M | $9M |
|---|
| Shared Savings | $83M | $133M | $170M | $179M | $235M |
|---|
| $817.08M |
| +$30.71M |
| +3.91% |
| 2019 | $786.36M | +$128.75M | +19.58% |
